Showing results (51-60 of 287) with videos related to
Sort By:
Pageof 29
Advances in Immunology|May 22, 2012
Mapping lupus susceptibility genes in the NZM2410 mouse modelLaurence MorelTrends in Immunology|November 12, 2021
Erythrocyte-derived mitochondria: an unexpected interferon inducer in lupusLaurence MorelClinical Immunology (Orlando, Fla.)|July 28, 2012
Metabolic regulation of organelle homeostasis in lupus T cellsTiffany N Caza, Gergely Talaber, Andras PerlFree Radical Biology & Medicine|April 28, 2007
Nitric oxide, mitochondrial hyperpolarization, and T cell activationGyorgy Nagy, Agnes Koncz, David Fernandez, et al.Clinical Immunology (Orlando, Fla.)|April 12, 2015
Oxidative stress and Treg depletion in lupus patients with anti-phospholipid syndromeZhi-wei Lai, Ivan Marchena-Mendez, Andras PerlThe Journal of Clinical Psychiatry|June 13, 2012
Psychiatric symptoms in systemic lupus erythematosus: a systematic reviewZsuzsa Szombathyne Meszaros, Andras Perl, Stephen V FaraoneClinical Immunology Communications|April 15, 2024
Appraising SARS-CoV-2 infections after full mRNA COVID-19 vaccination in patients with systemic lupus erythematosus (SLE)Anderson Anuforo, Michael Sandhu, Jianghong Yu, et al.Antioxidants & Redox Signaling|September 7, 2002
Metabolic switches of T-cell activation and apoptosisAndras Perl, Peter Gergely, Ferenc Puskas, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|January 12, 2007
Signaling abnormalities in systemic lupus erythematosus as potential drug targetsDavid Fernandez, Eduardo Bonilla, Paul Phillips, et al.Clinical Immunology (Orlando, Fla.)|March 23, 2020
Nine-test panel has superior sensitivity to detect antiphospholipid antibody syndrome in patients with or without SLEKonrad Dziamski, Saika Sharmeen, Katalin Banki, et al.Pageof 29